Sustaining chicken-meat production with alternative protein sources. This project aims to secure sustainable chicken-meat production by the radical reduction or even elimination of imported soybean meal as the primary protein source in Australian broiler diets by its replacement with feed-grade amino acids and local feedstuffs. This project will expand our comprehension of starch/glucose and protein/amino acid digestive dynamics in poultry diets based on wheat, the primary feed grain in Australi ....Sustaining chicken-meat production with alternative protein sources. This project aims to secure sustainable chicken-meat production by the radical reduction or even elimination of imported soybean meal as the primary protein source in Australian broiler diets by its replacement with feed-grade amino acids and local feedstuffs. This project will expand our comprehension of starch/glucose and protein/amino acid digestive dynamics in poultry diets based on wheat, the primary feed grain in Australia; however, wheat does inherently possess nutritional disadvantages. Expected outcomes include soybean meal-free feed formulations for the Australian chicken-meat industry to enhance the affordable and environmentally viable production of chicken-meat coupled with improved bird welfare and flock health. Read moreRead less
Manipulation of the growth potential and carcass composition of domestic animal species. Finding alternatives to repeated growth hormone(GH) injection to boost production efficiency and minimise carcass fatness remains an important target for animal research. This application exploits the two novel approaches to achieve this goal through: 1. the administration of the GH releasing peptides to the neonate to imprint an enhanced GH secretory pattern and feed conversion efficiency during growth ....Manipulation of the growth potential and carcass composition of domestic animal species. Finding alternatives to repeated growth hormone(GH) injection to boost production efficiency and minimise carcass fatness remains an important target for animal research. This application exploits the two novel approaches to achieve this goal through: 1. the administration of the GH releasing peptides to the neonate to imprint an enhanced GH secretory pattern and feed conversion efficiency during growth to maturity and 2. the development of an orally active form of these peptides by conjugation with VitB12 to facilitate intestinal absorption through the VitB12 transport mechanism for delivery to the hypothalamic/pituitary axis of animals nearing maturity.Read moreRead less
Genomic sequencing and comparative genomic analysis for animal bacterial vaccine discovery. The aim of this project is to develop vaccines for the control of swine dysentery (pigs) and intestinal spirochaetosis (pigs and chickens). These infections cause important production-limiting diseases for which no effective vaccines are available. We will use whole genomic sequencing of the two causal species of intestinal spirochaetal bacteria, with a bioinformatics-based analysis of the data to identif ....Genomic sequencing and comparative genomic analysis for animal bacterial vaccine discovery. The aim of this project is to develop vaccines for the control of swine dysentery (pigs) and intestinal spirochaetosis (pigs and chickens). These infections cause important production-limiting diseases for which no effective vaccines are available. We will use whole genomic sequencing of the two causal species of intestinal spirochaetal bacteria, with a bioinformatics-based analysis of the data to identify potential cell surface structures that will be tested as the basis of new recombinant vaccines. Outcomes will include the development of new commercial products, increased institutional capacity in veterinary vaccine discovery, and ultimately improved animal health and production in rural Australia.Read moreRead less
Vaccination of poultry infected with multiple Salmonella serovars. Salmonella is a zoonotic, foodborne pathogen found on eggs and poultry meat. It is the second largest cause of human gastrointestinal disease, thus, reduction of Salmonella on poultry farms is paramount to public health. This project aims to evaluate the long-term efficacy of a commercial Salmonella Typhimurium vaccine against multiple serotypes, including the emerging Salmonella Enteritidis. This project will generate new knowle ....Vaccination of poultry infected with multiple Salmonella serovars. Salmonella is a zoonotic, foodborne pathogen found on eggs and poultry meat. It is the second largest cause of human gastrointestinal disease, thus, reduction of Salmonella on poultry farms is paramount to public health. This project aims to evaluate the long-term efficacy of a commercial Salmonella Typhimurium vaccine against multiple serotypes, including the emerging Salmonella Enteritidis. This project will generate new knowledge in avian immunology using an innovative approach to evaluate the host response to multi-serovar infection. Outcomes of this project will future proof the Australian poultry industry against exotic Salmonella serotypes benefitting the industry by significantly reducing risks of future outbreaks and economic loss.Read moreRead less
Development of a live vaccine for gut health in poultry. Development of a live vaccine for gut health in poultry. The project aims to develop a live vaccine against necrotic enteritis, a disease of poultry estimated to cost the global poultry industry $5-6 billion USD/annum. It builds on work that has demonstrated the efficacy of an experimental vaccine. The proven antigen, NetB, will be expressed in live delivery vehicles, including the apicomplexan parasite Eimeria and several bacteria strains ....Development of a live vaccine for gut health in poultry. Development of a live vaccine for gut health in poultry. The project aims to develop a live vaccine against necrotic enteritis, a disease of poultry estimated to cost the global poultry industry $5-6 billion USD/annum. It builds on work that has demonstrated the efficacy of an experimental vaccine. The proven antigen, NetB, will be expressed in live delivery vehicles, including the apicomplexan parasite Eimeria and several bacteria strains particularly suited to use in chickens. Comparative analysis of the different vaccine vehicles will allow evaluation of the relative advantages and disadvantage of the different vehicles for delivery of heterologous vaccine antigens, thus informing the choice of appropriate vectors for this and other vaccine applications.Read moreRead less
Reducing the health & economic burden of Campylobacter using a live vaccine. The aim of the project is to develop a vaccine to reduce Campylobacter bacteria in chickens. Campylobacters cause disease in both poultry and humans. Poultry products are the most common source of human infections. By reducing Campylobacter in poultry, the transfer to humans will be reduced. The expected outcomes arising from this work will be a reduction of the economic burden of poultry losses, in an Australian indust ....Reducing the health & economic burden of Campylobacter using a live vaccine. The aim of the project is to develop a vaccine to reduce Campylobacter bacteria in chickens. Campylobacters cause disease in both poultry and humans. Poultry products are the most common source of human infections. By reducing Campylobacter in poultry, the transfer to humans will be reduced. The expected outcomes arising from this work will be a reduction of the economic burden of poultry losses, in an Australian industry valued at $2.8 billion/year, and an improvement in food safety, thus helping to reduce the burden of foodborne illness, estimated to be $1.2 billion dollars/year. This project is, therefore, poised to benefit the Australian economy, specifically primary producers and the general public, by targeted vaccination of poultry.Read moreRead less
Development of novel omega-3 enriched poultry products. New Health recommendations and changes to the Food Standards Code encourage greater dietary intake of omega-3 (w-3) fatty acids. Our core research on modifying fatty acid composition of poultry tissues and preliminary studies with our industry partner's proprietary fishmeal product (PorcOmega) have indicated the feasibility of producing novel meat products and eggs with high w-3 contents, which would qualify to carry a new nutrition label. ....Development of novel omega-3 enriched poultry products. New Health recommendations and changes to the Food Standards Code encourage greater dietary intake of omega-3 (w-3) fatty acids. Our core research on modifying fatty acid composition of poultry tissues and preliminary studies with our industry partner's proprietary fishmeal product (PorcOmega) have indicated the feasibility of producing novel meat products and eggs with high w-3 contents, which would qualify to carry a new nutrition label. We now propose, in collaboration with our industry partner, to assess the viability of producing such products by conducting poultry feeding trials with PorcOmega on a commercial scale and evaluating both the levels of w-3 enrichement of chicken breast, thigh and sausages, shelf-life and consumer acceptability (sensory evaluation) of these products. We expect to establish feeding strategies for adoption by commercial producers of premium poultry and eggs for local or export markets.Read moreRead less
Using transgenic plant-based production and delivery systems to develop an avian influenza vaccine. This project aims to provide proof-of-concept for the rapid production of plant-made vaccines of high strategic value to the poultry industry. Plant-made AI vaccines would help safeguard primary industries in Australia from exotic influenza strains and shield rural communities from the impact of stock losses. This collaboration will also contribute to the Molecular Farming industry by ensuring tha ....Using transgenic plant-based production and delivery systems to develop an avian influenza vaccine. This project aims to provide proof-of-concept for the rapid production of plant-made vaccines of high strategic value to the poultry industry. Plant-made AI vaccines would help safeguard primary industries in Australia from exotic influenza strains and shield rural communities from the impact of stock losses. This collaboration will also contribute to the Molecular Farming industry by ensuring that Australian interests are considered as this frontier technology tackles the challenges of turning academic research into marketable products. The key features of an oral plant-made AI vaccine, including rapid and non-egg based production, also make this an attractive technology for the future development of swine and human influenza vaccines.Read moreRead less
Evaluation of Bacillus amyloliquefaciens H57 as a probiotic in livestock using animal nutrition studies and metagenomics. To improve animal production, gene sequencing will unravel how microbial communities in the rumen of sheep and cattle and the gastro intestinal tract of poultry respond to feed quality and probiotic bacteria. The animal nutrition trials will also measure weight gain and feed utilisation efficiency, particularly for nitrogen, protein and energy.